Comparative mortality of patients diagnosed with localized and in situ melanomas.
BACKGROUND
The rates for incidence and mortality from melanoma are continuing to rise, although long term survival experience for patients with in situ and localized melanomas is favorable.


RESULTS
Excess mortality varied with age at diagnosis, sex, duration since diagnosis and tumor thickness.


CONCLUSIONS
Compared to the general white population in the United States, patients with localized melanoma experience a mild increase in Excess Death Rates (EDRs) the first year following diagnosis. For 1-5 years following diagnosis the EDRs are markedly increased across all age groups and decline thereafter. At 15-20 years following diagnosis the EDRS are not elevated except among patients < 40 years of age at diagnosis. Patients with tumors > 1.5 mm thick have mild to moderate increases in EDR for the first year following diagnosis, and extremely high EDRs up to 5 years. There is no elevation in mortality ratios or EDR for patients diagnosed with in situ melanomas.
Harrison
R A
RA
Biostatistics Unit Comprehensive Cancer Center, University of Alabama at Birmingham 35294-3300, USA.
Soong
S J
SJ
Lee
J A
JA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002278:Carcinoma in Situ / Q000401:mortality* / Q000473:pathology; D002423:Cause of Death; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000401:mortality* / Q000473:pathology; D008875:Middle Aged; D016017:Odds Ratio; D012878:Skin Neoplasms / Q000401:mortality* / Q000473:pathology; D015996:Survival Rate